A genomic perspective on human proteases as drug targets

Drug Discovery Today

Volumn 6, Issue 13, 2001, Pages 681-688

  Southan, Christopher ^a  

^a Gemini Genomics ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN; PROTEINASE;

BIOTECHNOLOGY; DATA BASE; DNA POLYMORPHISM; DRUG INDUSTRY; DRUG TARGETING; GENE SEQUENCE; GENERAL ASPECTS OF DISEASE; GENOME; HUMAN; INFORMATION SCIENCE; MEDICAL GENETICS; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; PROTEIN FAMILY; REVIEW; RNA SPLICING;

EID: 0035398526     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(01)01793-7     Document Type: Review

References (42)

1. The impact of genomics on drug discovery
2. Protease inhibitors: current status and future prospects
3. Initial sequencing and analysisi of the human genome
4. MEROPS: the peptidase database
5. Assessing the protease and protease inhibitor content of the human genome
6. A novel superfamily of predicted cysteine proteases from eukaryotes, viruses and Chlamydia pnemoniae
7. New roles for structure in biology and drug discovery
8. The role of presenilins in gamma-secretase activity
9. The PA domain: a protease associated domain
10. Website review: InterPro the integrated resource of protein functional domains
11. The InterPro database, an integrated documentation resource for protein families, domains and functional sites
12. Sequencing and expression analysis of the serine protease gene cluster located in chromosome 19q13 region
13. Characterization of human gamma-tryptases, novel members of the chromosome 16p mast cell tryptase and prostasin gene families
14. Napsins: new human aspartic proteinases. Distinction between two closely related genes
15. Alternative splicing: increasing diversity in the proteomic world
16. Physiological non-equivalence of the two forms of angiotensin converting enzyme
17. A splice variant of beta-secretase deficient in the amyloidogenic processing of the amyloid precursor protein
18. Single nucleotide polymorphisms as tools in human genetics
19. Sequence variation in the human angiotensin converting enzyme
20. Genetic variation in the gene encoding calpian-10 is associated with type-2 diabetes mellitus
21. A human homologue of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase
22. Mechanisms involved in cartilage proteoglycan catabolism
23. Identification of a novel aspartic protease (Asp 2) as beta-secretase
24. ASP1 (BACE2) cleaves the amyloid precursor protein at the β-secretase site
25. Quo vadis, biotech (Part 1)
26. Using bioinformatics in gene and drug discovery
27. Bioinformatic analysis of mRNA heterogeneity in the putative Alzheimer's beta-secretase, Asp2
28. The new human kallikrein gene family: implications in carcinogenesis
29. In search of an enzyme: the β-secretase of Alzheimer's disease is an aspartic proteinase
30. Structure of the protease domain of memapsin 2 (β-secretase) complexed with inhibitor
31. Mice deficient in BACE1, the Alzheimer's beta-secretase, have normal phenotype and abolished beta-amyloid generation
32. Rapid and general profiling of protease specificities by using combinatorial flourogenic substrate libraries
33. Substrate specificity of human collagenase 3 assessed using a phage-displayed peptide library
34. Gene expression profiling: monitoring transcription and translation products using DNA microarrays and proteomics
35. Human HtrA, an evolutionarily conserved serine protease identified as a differentially expressed gene product in osteoarthritic cartilage
36. Characterization of a novel human serine protease that has extensive homology to bacterial heat shock endoprotease HtrA and is regulated by kidney ischemia
37. Characterization of human HtrA2, a novel serine protease involved in the mammalian cellular stress response
38. Inhibition of CD23 processing correlates with inhibition of IL-4-stimulated IgE production in human PBL and hu-PBL-reconstituted SCID mice
39. Regulated intramembrane proteolysis, a control mechanism conserved from bacteria to humans
40. Adamalysins. A family of metzincins including TNF-alpha converting enzyme (TACE)
41. Characterization of myelin-associated glycoprotein (MAG) proteolysis in the human central nervous system